de tuinman schreef op 11 september 2019 12:51:
From an ef?cacy point of view, what we see is a dramatically fast onset of action. In our myasthenia gravis patients, after the ?rst infusion, you already have a statistically signi?cant separation from placebo, same in pemphigus vulgaris. I mean, after the ?rst infusion, we basically see in our PV patients a dramatic response in terms of disease control. Maybe that is linked to that very fast traveling of the molecule to the tissues. Remember the very-high biodistribution I was talking about.